NCT07507734 Occlusal Splint and Exercise Therapy for Temporomandibular Disorders
| NCT ID | NCT07507734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acibadem University |
| Condition | Temporomandibular Disorders (TMD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2026-07-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2025-07-10 with a primary completion date of 2026-07-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an exercise protocol can improve temporomandibular pain, jaw function and muscle mechanical properties in individuals with Temporomandibular Disorders (TMD). This study focuses on patients who are already receiving occlusal splint therapy. The main question it aims to answer is: How does the addition of an exercise protocol to occlusal splint therapy affect temporomandibular pain, jaw function and muscle mechanical properties of the masticatory and neck muscles? Researchers will compare the group receiving both occlusal splint therapy and the exercise protocol to a group only occlusal splint therapy to see if the combined approach is more effective. Participants will: * Undergo an initial assessment of the Jaw Functional Limitation Scale-20 (JLFS-20), Craniofacial Pain and Disability Inventory (CF-PDI), Graded Chronic Pain Scale Version 2.0 (GCPS-2.0), jaw range of motion, pain pressure threshold and muscle mechanical properties. * Receive occlusal splint therapy as a part of their treatment. * Perform a structured exercise protocol (only 1 group) * Attend follow up sessions at the 4th week to monitor changes in all initial assessment parameters.
Eligibility Criteria
Inclusion Criteria: * Clinical and radiological diagnosis of TMD * Being between 18-65 years of age * Presence of Temporomandibular Joint (TMJ) pain for the last 3 months. Exclusion Criteria: * Intra-articular or degenerative joint disorders and subluxation requiring immediate treatment, * A history of TMJ or cervical region surgery in the last 3 months, * A history of treatment from related regions, * The presence of rheumatic diseases, including TMJ diseases, * TMJ instability or fracture, * The presence of perception-cognition disorder, * The presence of chronic pain, such as trigeminal neuralgia.
Contact & Investigator
Helin Yavuz, Physiotherapist
PRINCIPAL INVESTIGATOR
Acibadem University
Frequently Asked Questions
Who can join the NCT07507734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Temporomandibular Disorders (TMD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07507734 currently recruiting?
Yes, NCT07507734 is actively recruiting participants. Contact the research team at Helin.Yavuz1@live.acibadem.edu.tr for enrollment information.
Where is the NCT07507734 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07507734 clinical trial?
NCT07507734 is sponsored by Acibadem University. The principal investigator is Helin Yavuz, Physiotherapist at Acibadem University. The trial plans to enroll 38 participants.